029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
RLN807肺癌及边缘组织组合芯片,附病理分级、TNM、临床分期,80例/80点
点 数80例 数80
行 数8列 数10
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:RLN807
 
肺癌及边缘组织组合微阵列芯片,包含26例腺癌,4例腺磷癌,30例鳞状细胞癌,6例小细胞癌,4例大细胞癌,10例边缘肺组织,一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Lun
-Lung
 
Malignant (IB)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (IIIA)
 
Malignant (IIIB)
 
NAT (*)
TISSUE  ARRAYS RLN807
1
2
3
4
5
6
7
8
9
10
A
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
B
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
C
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
D
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
E
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
F
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
G
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
H
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
LUN
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1149FLungAdenocarcinoma with necrosis1--2T2N0M0IBMalignant*N
A2263FLungAdenocarcinoma with necrosis1--2T2bN0M0IIAMalignant*N
A3365MLungAdenocarcinoma2T3N0M0IIBMalignant7.5*5.0*4.0N
A4462MLungAdenocarcinoma2T2aN0M0IBMalignant7.5*5.0*4.0N
A5568MLungMucinous adenocarcinoma2T2N0M0IBMalignant5*4.5*3N
A6670MLungAdenocarcinoma2T3N1M0IIIAMalignant*N
A7743FLungAdenocarcinoma2T2N0M0IBMalignant3.5*3*2.5N
A8837FLungAdenocarcinoma with necrosis2T2N0M0IBMalignant*N
A9964MLungAdenocarcinoma2T2N0M0IBMalignant3.5*3*3N
A101039FLungAdenocarcinoma2T2bN0M0IIAMalignant8*6N
B11159MLungAdenocarcinoma with necrosis2T2bN0M0IIAMalignant*N
B21242MLungAdenocarcinoma2T2N0M0IBMalignant*N
B31359MLungAdenocarcinoma2T2aN0M0IBMalignant*N
B41448MLungAdenocarcinoma2T2N1M0IIBMalignant*N
B51565MLungAdenocarcinoma2T2aN0M0IBMalignant*N
B61654MLungAdenocarcinoma2T2aN0M0IBMalignant*N
B71742MLungAdenocarcinoma2--3T2aN0M0IBMalignant*N
B81848FLungAdenocarcinoma2--3T2aN0M0IBMalignant*N
B91939FLungAdenocarcinoma with necrosis2--3T3N0M0IIBMalignant5.0N
B102045FLungAdenocarcinoma with degenerate3T2N0M0IBMalignant*N
C12156FLungMucinous adenocarcinoma with necrosis3T2aN1M0IIBMalignant*N
C22248MLungAdenocarcinoma3T2aN0M0IBMalignant*N
C32370MLungAdenocarcinoma3T2N0M0IBMalignant6.5*4.5*4N
C42453MLungAdenocarcinoma3T2N0M0IBMalignant9.5*7*6N
C52570MLungAdenocarcinoma3T2aN2M0IIIAMalignant*N
C62651MLungAdenocarcinoma3T2aN0M0IBMalignant*N
C72765MLungAdenosquamous carcinoma*T2N0M0IBMalignant*N
C82855FLungAdenosquamous carcinoma*T2N1M0IIBMalignant*N
C92950MLungAdenosquamous carcinoma*T2N1M0IIBMalignant*N
C103068MLungAdenosquamous carcinoma with necrosis*T2N0M0IBMalignant*N
D13130MLungSquamous cell carcinoma1--2T2N0M0IBMalignant4.5*4*3N
D23250MLungSquamous cell carcinoma (sparse)1--2T2N0M0IBMalignant7.5*5*4N
D33330MLungSquamous cell carcinoma with necrosis2T2N0M0IBMalignant5*3*3N
D43458MLungSquamous cell carcinoma with necrosis2T3N1M0IIIAMalignant4*4*3N
D53548MLungSquamous cell carcinoma2T2N1M0IIBMalignant*N
D63652FLungSquamous cell carcinoma2T2N0M0IBMalignant*N
D73759MLungSquamous cell carcinoma2T2N0M0IBMalignant*N
D83860FLungSquamous cell carcinoma2T2N1M0IIBMalignant5*4*4N
D93947MLungSquamous cell carcinoma with necrosis2T2aN0M0IBMalignant*N
D104057MLungSquamous cell carcinoma with necrosis2T2N0M0IBMalignant8*8*7N
E14170MLungSquamous cell carcinoma2T3N0M0IIBMalignant5*4*4N
E24263MLungSquamous cell carcinoma with necrosis2T2bN0M0IIAMalignant*N
E34369MLungSquamous cell carcinoma2T2N0M0IBMalignant*N
E44472MLungSquamous cell carcinoma2T2N1M0IIBMalignant7*3*1.5N
E54556MLungSquamous cell carcinoma2T3N0M0IIBMalignant6.5*5*5N
E64667MLungSquamous cell carcinoma with necrosis2T2bN0M0IIAMalignant4*3.5*3N
E74746MLungSquamous cell carcinoma with necrosis2T3N1M0IIIAMalignant*N
E84869MLungSquamous cell carcinoma2T2N1M0IIBMalignant7*5*4N
E94968MLungSquamous cell carcinoma (sparse)2T3N0M0IIBMalignant6*4*3.5N
E105053FLungSquamous cell carcinoma2T2N1M0IIBMalignant*N
F15162MLungSquamous cell carcinoma2T2N1M0IIBMalignant*N
F25255MLungSquamous cell carcinoma2T2bN0M0IIAMalignant5.5*4*3.5N
F35353MLungSquamous cell carcinoma2T2aN1M0IIBMalignant*N
F45468MLungSquamous cell carcinoma with necrosis2T2N2M0IIIAMalignant*N
F55555MLungSquamous cell carcinoma2T2aN0M0IBMalignant*N
F65654MLungSquamous cell carcinoma with necrosis2T2N0M0IBMalignant10*9*5N
F75761MLungSquamous cell carcinoma with necrosis2T2aN0M0IBMalignant*N
F85863MLungSquamous cell carcinoma2--3T3N2M0IIIBMalignant*N
F95946FLungSquamous cell carcinoma with necrosis3T2N0M0IBMalignant*N
F106071MLungSquamous cell carcinoma3T2N0M0IBMalignant*N
G16161MLungSmall cell carcinoma*T2aN0M0IBMalignant3.5*3*0.7N
G26252MLungSmall cell carcinoma (degeneration and necrosis)*T2N0M0IBMalignant4*5N
G36352MLungSmall cell carcinoma with necrosis*T2aN0M0IBMalignant4.0N
G46439MLungSmall cell carcinoma*T2N1M0IIBMalignant*N
G56548MLungSmall cell carcinoma (degeneration and necrosis)*T2N0M0IBMalignant*N
G66657MLungSmall cell carcinoma*T2bN0M0IIAMalignant4.5*4.5*3.0N
G76747FLungLarge cell carcinoma*T2N2M0IIIAMalignant*N
G86839MLungLarge cell carcinoma*T2aN0M0IBMalignant*N
G96957FLungLarge cell carcinoma*T2aN0M0IBMalignant*N
G107064MLungLarge cell carcinoma*T2aN0M0IBMalignant*N
H17164MLungAdjacent normal lung tissue***NAT*N
H27248FLungAdjacent normal lung tissue***NAT*N
H37370MLungAdjacent normal lung tissue***NAT*N
H47458MLungAdjacent normal lung tissue***NAT*N
H57552MLungAdjacent normal lung tissue***NAT*N
H67665FLungAdjacent normal lung tissue***NAT*N
H77748MLungAdjacent normal lung tissue***NAT*N
H87843MLungAdjacent normal lung tissue***NAT*N
H97957MLungAdjacent normal lung tissue***NAT*N
H108063FLungAdjacent normal lung tissue***NAT*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情